Browsing Tag
cancers
24 posts
Breaking Cancer Barriers: ImmunityBio’s ANKTIVA Triumph
ImmunityBio (IBRX) announced positive results from the QUILT 3.055 study evaluating ANKTIVA (N-803) in 2nd- and 3rd-line NSCLC…
Bristol Myers Squibb’s Krazati: A Potential Game Changer in Cancer Treatment
In a groundbreaking development, Bristol Myers Squibb (BMY) recently announced promising results for their cancer pill, Krazati, in…
AstraZeneca’s Acquisition of Fusion: A Step Forward in Radiopharmaceutical Innovation
In the rapidly evolving landscape of biopharmaceuticals, mergers and acquisitions serve as key indicators of industry trends and…
Advancing Cell Therapy for Lupus Treatment: A Promising Frontier
In the realm of medical innovation, cell therapy has emerged as a revolutionary approach with the potential to…
FDA Approves Amtagvi for Melanoma
In a groundbreaking development in the field of oncology, the Food and Drug Administration (FDA) has granted approval…
Regeneron’s Bright Future: Analysts Raise Price Targets Following Impressive Q4 Results
Regeneron Pharmaceuticals, a leading biotechnology company known for its innovations in treating eye diseases, allergies, and cancer, has…
